Woman's death will be focus of 2nd Xarelto Trial
A month after drugmakers Johnson & Johnson and Bayer prevailed in the first trial over allegations of harm caused by the blood thinner Xarelto, the second bellwether case has gone to trial in New Orleans.
This time, the family of a woman who died about a year after she started taking the drug for atrial fibrillation is accusing the drugmakers of responsibility for her fatal hemorrhagic stroke.
Sharyn Orr, of Louisiana, died in May 2015 at the age of 67 after being in a coma for 10 days.
The family’s lawyers say her death was “completely avoidable.”
TriMark Legal Funding provides non-recourse pre-settlement and post-settlement Xarelto lawsuit loans to injured plaintiffs nationwide.
This post originally appeared here: https://www.drugwatch.com/news/2017/06/09/xarelto-second-trial-avoidable-death/
Click here to see the full original article.